Literature DB >> 15546578

Survival after resection for lung cancer is the outcome that matters.

Michael F Reed1, Mark Molloy, Erica L Dalton, John A Howington.   

Abstract

BACKGROUND: Lung cancer is the leading cause of cancer mortality in the United States. Stage-specific survival is well documented in national data sets; however, there remains limited recording of longitudinal survival in individual centers.
METHODS: The VistA Surgery Package was employed to list operations performed by the thoracic surgery service at one Veterans Administration (VA) Medical Center.
RESULTS: During a period of 107 months, 416 thoracic operations were performed, 211 of them for lung cancer. Stage distribution was 66% stage I, 18% stage II, 12% stage III, and 4% stage IV. During follow-up, 102 patients died, 57 of them from disease-specific causes. Median survival was 39 months for stage I. Disease-specific median survival was 83 months for stage I, and 5-year survival was 52% (72% for stage IA and 32% for stage IB).
CONCLUSIONS: Pulmonary resection offers high disease-free survival for early-stage lung cancer. Decentralized hospital computer programming (DHCP) allows individual oncology programs to reliably measure survival. Use of this important outcome measure in quality improvement programs facilitates realistic counseling of patients and meaningful assessments of practice effectiveness.

Entities:  

Mesh:

Year:  2004        PMID: 15546578     DOI: 10.1016/j.amjsurg.2004.07.037

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  9 in total

1.  MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.

Authors:  Xia Pu; Jack A Roth; Michelle A T Hildebrandt; Yuanqing Ye; Hua Wei; John D Minna; Scott M Lippman; Xifeng Wu
Journal:  Cancer Res       Date:  2013-02-01       Impact factor: 12.701

2.  DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer.

Authors:  Junying Wang; Limei Sun; Mingyue Yang; Wenting Luo; Ying Gao; Zihui Liu; Xueshan Qiu; Enhua Wang
Journal:  J Histochem Cytochem       Date:  2013-04-09       Impact factor: 2.479

3.  The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: association with migration, invasion and prediction of distant metastasis.

Authors:  Wen-Liang Chen; Kuang-Tai Kuo; Teh-Ying Chou; Chien-Lung Chen; Chih-Hao Wang; Yau-Huei Wei; Liang-Shun Wang
Journal:  BMC Cancer       Date:  2012-06-29       Impact factor: 4.430

4.  A classification method based on principal components of SELDI spectra to diagnose of lung adenocarcinoma.

Authors:  Qiang Lin; Qianqian Peng; Feng Yao; Xu-Feng Pan; Li-Wen Xiong; Yi Wang; Jun-Feng Geng; Jiu-Xian Feng; Bao-Hui Han; Guo-Liang Bao; Yu Yang; Xiaotian Wang; Li Jin; Wensheng Guo; Jiu-Cun Wang
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

Review 5.  Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system.

Authors:  Leah L Zullig; Christina D Williams; Alice G Fortune-Britt
Journal:  Cancer Manag Res       Date:  2015-01-14       Impact factor: 3.989

6.  High expression of long non-coding RNA SBF2-AS1 promotes proliferation in non-small cell lung cancer.

Authors:  Junjie Lv; Mantang Qiu; Wenjia Xia; Chao Liu; Youtao Xu; Jie Wang; Xuechun Leng; Su Huang; Rong Zhu; Ming Zhao; Fengqing Ji; Lin Xu; Keping Xu; Rong Yin
Journal:  J Exp Clin Cancer Res       Date:  2016-05-06

7.  The prognostic significance of long noncoding RNAs in non-small cell lung cancer: a meta-analysis.

Authors:  Wei Jing; Nandi Li; Yingchao Wang; Xuefang Liu; Shengjun Liao; Hongyan Chai; Jiancheng Tu
Journal:  Oncotarget       Date:  2017-01-17

Review 8.  Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening.

Authors:  Dean H Conrad; Jesse Goyette; Paul S Thomas
Journal:  J Gen Intern Med       Date:  2008-01       Impact factor: 5.128

Review 9.  Screening and Biosensor-Based Approaches for Lung Cancer Detection.

Authors:  Lulu Wang
Journal:  Sensors (Basel)       Date:  2017-10-23       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.